116 related articles for article (PubMed ID: 38690943)
1. TRPV1 signaling of perirenal adipose tissue promotes DOCA-Salt-induced hypertension and kidney injury.
Hua D; Huang W; Huang W; Xie Q; Tang L; Wu X; Gao M; Xu T; Zhang Y; Li P; Sun W; Kong X
J Hypertens; 2024 Aug; 42(8):1409-1420. PubMed ID: 38690943
[TBL] [Abstract][Full Text] [Related]
2. Role of the monocyte chemoattractant protein-1/C-C chemokine receptor 2 signaling pathway in transient receptor potential vanilloid type 1 ablation-induced renal injury in salt-sensitive hypertension.
Wang Y; Zhu M; Xu H; Cui L; Liu W; Wang X; Shen S; Wang DH
Exp Biol Med (Maywood); 2015 Sep; 240(9):1223-34. PubMed ID: 25585624
[TBL] [Abstract][Full Text] [Related]
3. Protective effect of TRPV1 against renal fibrosis via inhibition of TGF-β/Smad signaling in DOCA-salt hypertension.
Wang Y; Wang DH
Mol Med; 2011; 17(11-12):1204-12. PubMed ID: 21792478
[TBL] [Abstract][Full Text] [Related]
4. Aggravated renal inflammatory responses in TRPV1 gene knockout mice subjected to DOCA-salt hypertension.
Wang Y; Wang DH
Am J Physiol Renal Physiol; 2009 Dec; 297(6):F1550-9. PubMed ID: 19794112
[TBL] [Abstract][Full Text] [Related]
5. Deletion of transient receptor potential vanilloid type 1 receptors exaggerates renal damage in deoxycorticosterone acetate-salt hypertension.
Wang Y; Babánková D; Huang J; Swain GM; Wang DH
Hypertension; 2008 Aug; 52(2):264-70. PubMed ID: 18606907
[TBL] [Abstract][Full Text] [Related]
6. [Role of transient receptor potential vanilloid type 1 and C-C chemokine receptor 2 in renal injury induced by salt-sensitive hype].
Zhu FY; Liu WH; Wang XX; Cui L; Shen S; Zhu MJ; Wang YP
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2014 Oct; 36(5):488-95. PubMed ID: 25360645
[TBL] [Abstract][Full Text] [Related]
7. Activation of TRPV4 by dietary apigenin antagonizes renal fibrosis in deoxycorticosterone acetate (DOCA)-salt-induced hypertension.
Wei X; Gao P; Pu Y; Li Q; Yang T; Zhang H; Xiong S; Cui Y; Li L; Ma X; Liu D; Zhu Z
Clin Sci (Lond); 2017 Apr; 131(7):567-581. PubMed ID: 28143892
[TBL] [Abstract][Full Text] [Related]
8. Sodium butyrate ameliorates deoxycorticosterone acetate/salt-induced hypertension and renal damage by inhibiting the MR/SGK1 pathway.
Wu C; Chen Z; Zhang L; Zhu Y; Deng M; Huang C; Liu Y; Zhu Q; Wang L
Hypertens Res; 2021 Feb; 44(2):168-178. PubMed ID: 32908237
[TBL] [Abstract][Full Text] [Related]
9. Distribution, Morphological Characterization, and Resiniferatoxin-Susceptibility of Sensory Neurons That Innervate Rat Perirenal Adipose Tissue.
Liu BX; Qiu M; Zong PY; Chen XG; Zhao K; Li Y; Li P; Sun W; Kong XQ
Front Neuroanat; 2019; 13():29. PubMed ID: 30930754
[TBL] [Abstract][Full Text] [Related]
10. Renal Medullary Overexpression of Sphingosine-1-Phosphate Receptor 1 Transgene Attenuates Deoxycorticosterone Acetate (DOCA)-Salt Hypertension.
Hu G; Xie D; Chen C; Wang W; Li PL; Ritter JK; Li N
Am J Hypertens; 2023 Aug; 36(9):509-516. PubMed ID: 37171128
[TBL] [Abstract][Full Text] [Related]
11. Resting Afferent Renal Nerve Discharge and Renal Inflammation: Elucidating the Role of Afferent and Efferent Renal Nerves in Deoxycorticosterone Acetate Salt Hypertension.
Banek CT; Knuepfer MM; Foss JD; Fiege JK; Asirvatham-Jeyaraj N; Van Helden D; Shimizu Y; Osborn JW
Hypertension; 2016 Dec; 68(6):1415-1423. PubMed ID: 27698066
[TBL] [Abstract][Full Text] [Related]
12. Targeted afferent renal denervation reduces arterial pressure but not renal inflammation in established DOCA-salt hypertension in the rat.
Banek CT; Gauthier MM; Baumann DC; Van Helden D; Asirvatham-Jeyaraj N; Panoskaltsis-Mortari A; Fink GD; Osborn JW
Am J Physiol Regul Integr Comp Physiol; 2018 Jun; 314(6):R883-R891. PubMed ID: 29513561
[TBL] [Abstract][Full Text] [Related]
13. Triptolide attenuates renal damage by limiting inflammatory responses in DOCA-salt hypertension.
Zhang J; Zhu M; Zhang S; Xie S; Gao Y; Wang Y
Int Immunopharmacol; 2020 Dec; 89(Pt A):107035. PubMed ID: 33045566
[TBL] [Abstract][Full Text] [Related]
14. CS-3150, a Novel Nonsteroidal Mineralocorticoid Receptor Antagonist, Shows Preventive and Therapeutic Effects On Renal Injury in Deoxycorticosterone Acetate/Salt-Induced Hypertensive Rats.
Arai K; Morikawa Y; Ubukata N; Tsuruoka H; Homma T
J Pharmacol Exp Ther; 2016 Sep; 358(3):548-57. PubMed ID: 27384074
[TBL] [Abstract][Full Text] [Related]
15. Detrimental role of sphingosine kinase 1 in kidney damage in DOCA-salt hypertensive model: evidence from knockout mice.
Lyu B; Wang W; Ji XY; Ritter JK; Li N
BMC Nephrol; 2020 May; 21(1):173. PubMed ID: 32393187
[TBL] [Abstract][Full Text] [Related]
16. Renal Inflammation in DOCA-Salt Hypertension.
Banek CT; Gauthier MM; Van Helden DA; Fink GD; Osborn JW
Hypertension; 2019 May; 73(5):1079-1086. PubMed ID: 30879356
[TBL] [Abstract][Full Text] [Related]
17. Ablation of TRPV1-positive nerves exacerbates salt-induced hypertension and tissue injury in rats after renal ischemia-reperfusion via infiltration of macrophages.
Yu SQ; Ma S; Wang DH
Clin Exp Hypertens; 2021 Apr; 43(3):254-262. PubMed ID: 33327798
[No Abstract] [Full Text] [Related]
18. Macrophage-dependent impairment of α
Mui RK; Fernandes RN; Garver HG; Van Rooijen N; Galligan JJ
Am J Physiol Heart Circ Physiol; 2018 Apr; 314(4):H863-H877. PubMed ID: 29351460
[TBL] [Abstract][Full Text] [Related]
19. COX-2-independent activation of renal (pro)renin receptor contributes to DOCA-salt hypertension in rats.
Wang F; Sun Y; Luo R; Lu X; Yang B; Yang T
Am J Physiol Renal Physiol; 2020 Oct; 319(4):F647-F653. PubMed ID: 32799674
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological inhibition of the NLRP3 inflammasome reduces blood pressure, renal damage, and dysfunction in salt-sensitive hypertension.
Krishnan SM; Ling YH; Huuskes BM; Ferens DM; Saini N; Chan CT; Diep H; Kett MM; Samuel CS; Kemp-Harper BK; Robertson AAB; Cooper MA; Peter K; Latz E; Mansell AS; Sobey CG; Drummond GR; Vinh A
Cardiovasc Res; 2019 Mar; 115(4):776-787. PubMed ID: 30357309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
